RATIONALE AND OBJECTIVES: Identifying and treating persons with latent tuberculosis (TB) infection (LTBI) at high risk for developing TB is part of the current TB elimination strategy. There are no specific criteria, other than medical risks, to designate groups as high risk for developing TB. We hypothesized that, if location-based screenings were done in communities where persons with genotypically clustered Mycobacterium tuberculosis resided, then persons with LTBI from recent transmission and with undiagnosed TB could be identified. METHODS: Location-based TB screenings were done in partnership with multiple community-based organizations using resources previously used for other types of screening. MAIN RESULTS: Location-based screenings identified one person with TB for every 83 screened, and one person with LTBI for every five screened. The yield of this targeted screening program for discovering persons with TB and LTBI exceeded what would be expected from nontargeted screening in a county with a TB incidence of 5.7 per 100,000 population. CONCLUSIONS: Genotyping combined with geographic information systems analysis can potentially be used to define high-risk status and to define areas for location-based TB screenings.
RATIONALE AND OBJECTIVES: Identifying and treating persons with latent tuberculosis (TB) infection (LTBI) at high risk for developing TB is part of the current TB elimination strategy. There are no specific criteria, other than medical risks, to designate groups as high risk for developing TB. We hypothesized that, if location-based screenings were done in communities where persons with genotypically clustered Mycobacterium tuberculosis resided, then persons with LTBI from recent transmission and with undiagnosed TB could be identified. METHODS: Location-based TB screenings were done in partnership with multiple community-based organizations using resources previously used for other types of screening. MAIN RESULTS: Location-based screenings identified one person with TB for every 83 screened, and one person with LTBI for every five screened. The yield of this targeted screening program for discovering persons with TB and LTBI exceeded what would be expected from nontargeted screening in a county with a TB incidence of 5.7 per 100,000 population. CONCLUSIONS: Genotyping combined with geographic information systems analysis can potentially be used to define high-risk status and to define areas for location-based TB screenings.
Authors: Patrick G T Cudahy; Jason R Andrews; Alyssa Bilinski; David W Dowdy; Barun Mathema; Nicolas A Menzies; Joshua A Salomon; Sourya Shrestha; Ted Cohen Journal: Lancet Infect Dis Date: 2018-12-13 Impact factor: 25.071
Authors: J Peter Cegielski; David E Griffith; Paul K McGaha; Melanie Wolfgang; Celia B Robinson; Patricia A Clark; Willis L Hassell; Valerie A Robison; Kerfoot P Walker; Charles Wallace Journal: Am J Public Health Date: 2012-10-18 Impact factor: 9.308
Authors: J Peter Cegielski; David E Griffith; Paul K McGaha; Melanie Wolfgang; Celia B Robinson; Patricia A Clark; Willis L Hassell; Valerie A Robison; Kerfoot P Walker; Charles Wallace Journal: Am J Public Health Date: 2014-04 Impact factor: 9.308
Authors: Neela D Goswami; Emily J Hecker; Carter Vickery; Marshall A Ahearn; Gary M Cox; David P Holland; Susanna Naggie; Carla Piedrahita; Ann Mosher; Yvonne Torres; Brianna L Norton; Sujit Suchindran; Paul H Park; Debbie Turner; Jason E Stout Journal: PLoS One Date: 2012-10-02 Impact factor: 3.240
Authors: McEwen Khundi; James R Carpenter; Marriott Nliwasa; Ted Cohen; Elizabeth L Corbett; Peter MacPherson Journal: BMJ Open Date: 2021-07-13 Impact factor: 2.692